Relationship between cyclic AMP, phosphodiesterase activity, calcium and contraction in intestinal smooth muscle.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism* / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology; D003106:Colon / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism*; D004357:Drug Synergism; D005769:Gastrointestinal Motility; D006003:Glycogen / Q000378:metabolism; D007093:Imidazoles / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000201:enzymology / Q000378:metabolism*; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism*; D011817:Rabbits; D014166:Transferases / Q000378:metabolism
D000319:Adrenergic beta-Antagonists; D007093:Imidazoles; D001285:Atropine; D002217:Carbachol; D006003:Glycogen; D000242:Cyclic AMP; D014166:Transferases; D010727:Phosphoric Diester Hydrolases; D002118:Calcium